Clinical application of tegafur suppositories for bladder tumor

A Tegafur suppository of 750 mg was administered daily to 20 patients with bladder tumors, whose ages ranged from 43 to 84 years (average age 63.7). Histological study revealed transitional cell papilloma in 6 cases, transitional cell carcinoma in 12 cases, squamous cell carcinoma in 1 case and mali...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 29(1983), 8 vom: 03. Aug., Seite 969-77
Auteur principal: Mishina, T (Auteur)
Autres auteurs: Kobayashi, T, Maegawa, M, Nakao, M, Nakagawa, S, Watanabe, H
Format: Article
Langue:Japanese
Publié: 1983
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Suppositories Tegafur 1548R74NSZ Fluorouracil U3P01618RT